Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Mom finds out she has cancer after noticing something was off while breastfeeding - 2Eating ultra-processed foods could raise precancerous polyp risk for women under 50, according to research
- 3Step by step instructions to Contrast Lab Precious stones and Normal Jewels
- 4The 1st full moon of 2026 rises tonight! Here's what to expect from January's supermoon Wolf Moon
- 5Monetary Strengthening: Assuming Command over Your Cash
- The 15 Best Business visionaries Under 40
- 6 Arranging Administrations to Change Your Open air Space
- Tasting America: An Excursion Through Darling Cheap Food Brands
- SpaceX launches Starlink missions in dual-coast spaceflight doubleheader (videos)
- RFK Jr. releases new dietary guidelines with emphasis on protein, full-fat dairy
- We tasted one of the 10,000 Hershey's Dubai chocolate bars being resold on eBay. Is it worth the hype?
- Climate change is straining Alaska's Arctic. A new mining road may push the region past the brink
- Fundamental Archives for Beginning Your Business
- The most effective method to Recognize an Excellent Lab Precious stone
